NYSE: SPCE

Virgin Galactic Holdings, Inc

CIK 0001706946 · SIC 4700 · Transportation Services

Micro by revenue · Mid by assets Revenue $2M Assets $816M as of Sep 27, 2026

Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.

Sign up free

Want to see a complete report first? Today's free report (MLKN 10-Q) is open in full — no account needed.

8-K Filed Aug 18, 2026 · Period ending Aug 18, 2026

Summary not yet generated.

8-K Filed Aug 12, 2026 · Period ending Aug 12, 2026

Virgin Galactic delays first commercial flight to Feb 2027, books $50M+ in new revenue

5 material changes detected. Sign up free to read the summary.

Partner

Trade SPCE commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

10-Q Filed Aug 12, 2026 · Period ending Jun 30, 2026 Critical

revenue $134,000, net income -$55.9M. Virgin Galactic flags going-concern doubt, delays commercial service to Feb 2027

5 material changes detected. Sign up free to read the summary.

8-K Filed Jun 22, 2026 · Period ending Jun 22, 2026

Virgin Galactic exchanges $52.5M of 2027 convertible notes for stock, cutting debt 75%

3 material changes detected. Sign up free to read the summary.

8-K Filed Jun 15, 2026 · Period ending Jun 11, 2026

Virgin Galactic shareholders approve 9.45M share increase for employee equity compensation

4 material changes detected. Sign up free to read the summary.

8-K Filed Jun 10, 2026 · Period ending Jun 10, 2026

Virgin Galactic redeems $30.5M debt with 6.7M shares, cuts interest burden ahead of Q4 launch

3 material changes detected. Sign up free to read the summary.

8-K Filed Jun 2, 2026 · Period ending Jun 2, 2026

Virgin Galactic redeems $30.5M debt via stock issuance to eliminate principal payments through 2027

4 material changes detected. Sign up free to read the summary.

8-K Filed May 28, 2026 · Period ending May 28, 2026 Red flag

Virgin Galactic settles 2022 stockholder derivative lawsuits, final approval hearing July 28

3 material changes detected. Sign up free to read the summary.

8-K Filed May 18, 2026 · Period ending May 18, 2026

Virgin Galactic redeems $10M debt with 3.8M shares, cuts interest ahead of Q4 launch

3 material changes detected. Sign up free to read the summary.

8-K Filed May 14, 2026 · Period ending May 14, 2026

Virgin Galactic reports Q1 2026 financial results

2 material changes detected. Sign up free to read the summary.

10-Q Filed May 14, 2026 · Period ending Mar 31, 2026 Critical

revenue $227,000, net income -$64.7M. Virgin Galactic flags going-concern doubt as cash falls 23.4%, delays commercial restart to Q4

5 material changes detected. Sign up free to read the summary.

8-K Filed Apr 30, 2026 · Period ending Apr 30, 2026

Virgin Galactic to redeem $10M debt with stock, faces $30M mandatory payment by September

4 material changes detected. Sign up free to read the summary.

8-K Filed Apr 24, 2026 · Period ending Apr 24, 2026

Virgin Galactic amends debt indenture to gain flexibility on note redemptions

3 material changes detected. Sign up free to read the summary.

8-K Filed Apr 21, 2026 · Period ending Apr 21, 2026

Virgin Galactic boosts CFO severance 50% in change-of-control scenarios

3 material changes detected. Sign up free to read the summary.

10-Q Filed Aug 6, 2025 · Period ending Jun 30, 2025

Summary not yet generated.

10-Q Filed May 15, 2025 · Period ending Mar 31, 2025

Summary not yet generated.

Latest financial statements

From 10-Q filed Aug 12, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.

As filed

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

(Unaudited; in thousands, except per share amounts)

Description Three months ended June 30, 2026 Three months ended June 30, 2025 Six months ended June 30, 2026 Six months ended June 30, 2025
Revenue 134 406 361 867
Operating expenses:
Spaceline operations 28,182 14,206 57,822 35,032
Research and development 4,339 20,121 11,051 53,431
Selling, general and administrative 28,556 31,850 54,107 62,400
Depreciation and amortization 3,983 4,171 7,899 8,394
Total operating expenses 65,060 70,348 130,879 159,257
Operating loss (64,926) (69,942) (130,518) (158,390)
Interest income 2,396 5,832 5,097 13,047
Interest expense (1,994) (3,247) (3,822) (6,487)
Gain on extinguishment of debt 8,639 — 8,639 —
Other income, net 26 40 60 74
Loss before income taxes (55,859) (67,317) (120,544) (151,756)
Income tax expense (benefit) 30 (37) 60 11
Net loss (55,889) (67,280) (120,604) (151,767)
Other comprehensive loss:
Foreign currency translation adjustment (7) 22 (10) 18
Unrealized gain (loss) on marketable securities 19 (134) (66) (310)
Total comprehensive loss (55,877) (67,392) (120,680) (152,059)
Net loss per share:
Basic and diluted (0.50) (1.47) (1.27) (3.74)
Weighted-average shares outstanding:
Basic and diluted 110,757 45,641 95,206 40,569

Condensed Consolidated Balance Sheets (Unaudited)

(Unaudited; in thousands, except share and per share amounts)

Description June 30, 2026 December 31, 2025
Assets
Current assets:
Cash and cash equivalents 187,340 144,727
Restricted cash 31,072 30,988
Marketable securities 67,714 162,313
Other current assets 26,457 34,870
Total current assets 312,583 372,898
Property, plant and equipment, net 465,848 388,730
Other non-current assets 37,845 41,551
Total assets 816,276 803,179
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable 20,758 15,163
Current portion of long-term debt 29,983 47,830
Customer deposits 80,270 78,535
Other current liabilities 61,510 67,795
Total current liabilities 192,521 209,323
Non-current liabilities:
Long-term debt 189,056 276,362
Other long-term liabilities 38,585 43,530
Total liabilities 420,162 529,215
Commitments and contingencies (Note 14)
Stockholders’ Equity
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding — —
Common stock, $0.0001 par value; 700,000,000 shares authorized; 141,277,897 and 73,326,504 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively 14 7
Additional paid-in capital 3,268,427 3,025,604
Accumulated deficit (2,872,383) (2,751,779)
Accumulated other comprehensive income 56 132
Total stockholders’ equity 396,114 273,964
Total liabilities and stockholders’ equity 816,276 803,179

Condensed Consolidated Statements of Cash Flows (Unaudited)

(Unaudited; in thousands)

Description Six months ended June 30, 2026 Six months ended June 30, 2025
Cash flows from operating activities:
Net loss (120,604) (151,767)
Stock-based compensation 10,944 9,601
Depreciation and amortization 7,899 8,394
Gain on extinguishment of debt (8,639) —
Amortization of debt issuance costs 918 1,143
Accretion of marketable securities purchased at a discount (810) (4,007)
Other non-cash items (11) (22)
Change in operating assets and liabilities:
Other current and non-current assets 7,139 (550)
Accounts payable 2,851 3,965
Customer deposits 1,735 (3,622)
Other current and non-current liabilities (5,095) 5,501
Net cash used in operating activities (103,673) (131,364)
Cash flows from investing activities:
Capital expenditures (80,373) (104,408)
Purchases of marketable securities (68,118) (220,925)
Proceeds from maturities and calls of marketable securities 163,465 355,959
Other investing activities 10 8
Net cash provided by investing activities 14,984 30,634
Cash flows from financing activities:
Payments of long-term debt (8,203) —
Payments of finance lease obligations (119) (98)
Proceeds from issuance of common stock pursuant to at-the-market offering 145,020 86,330
Transaction costs related to issuance of common stock pursuant to at-the-market offering (3,748) (2,552)
Other debt and equity transaction costs (247) —
Proceeds from issuance of common stock pursuant to employee stock purchase plan 476 —
Withholding taxes paid on behalf of employees on net settled stock-based awards (1,793) (108)
Net cash provided by financing activities 131,386 83,572
Net increase (decrease) in cash, cash equivalents and restricted cash 42,697 (17,158)
Cash, cash equivalents and restricted cash at beginning of period 175,715 210,885
Cash, cash equivalents and restricted cash at end of period 218,412 193,727
Cash and cash equivalents 187,340 163,547
Restricted cash 31,072 30,180
Cash, cash equivalents and restricted cash 218,412 193,727

Amounts as printed on the EDGAR/iXBRL face — (Unaudited; in thousands, except per share amounts); (Unaudited; in thousands, except share and per share amounts); (Unaudited; in thousands). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗

View AI report for this filing